Table 3: Logistic regression analysis.

Bivariate analysisMultivariate analysis
Odds ratio95% CIP valueOdds ratio95% CI value

Age1.040.99–1.080.0251.040.95–1.140.381
Disease duration1.121.05–1.19<0.0010.960.89–1.030.326
PD subtype2.371.22–4.600.0102.070.89–4.800.090
Motor fluctuations2.811.39–5.690.0041.910.75–5.620.200
Dyskinesia2.801.36–5.780.0050.980.33–2.870.972
Hoehn and Yahr3.062.04–4.60<0.0011.590.72–3.500.247
UPDRS1.061.03–1.09<0.0010.980.94–1.040.658
FOG4.422.24–8.72<0.0011.650.67–4.030.274
FOG questionnaire1.151.08–1.22<0.0011.010.89–1.220.131
Activities of daily living*0.960.94–0.97<0.0011.020.92–1.140.807
MMSE*0.910.85–0.980.0171.020.93–1.130.640
Tinetti Balance*0.800.74–0.86<0.0010.840.74–0.970.017
Tinetti Gait*0.800.73–0.87<0.0011.130.95–1.430.256
Tinetti total*0.890.85–0.93<0.0010.930.87–1.010.690
Get-up-and-go0.950.90–1.010.189
Levodopa dose1.0021.001–1.0040.0051.020.94–1.190.944
COMT-I use2.801.17–6.740.0213.411.06–11.370.052
Neuroleptic use12.341.48–102.980.0201.250.16–12.670.854
Cholinesterase inhibitor use11.922.12–12.340.0021.110.23–11.780.756

Abbreviations. PD: Parkinson disease; UPDRS: Unified Parkinson’s Disease Rating Scale; FOG: freezing of gait; MMSE: Minimental State Examination.
* Functional tests: higher scores means normality.